| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
CDT Equity Inc.
13D/A
Amendment 8
CDT · 20678X700
|
22.1% |
11/6/2026
Event 11/5/2026
|
|||
| Corvus Capital Ltd. | 16.8% | ||||
| Manoira Corporation | 14.5% | ||||
| Andrew Regan | 22.1% | ||||
|
CDT Equity Inc.
13D/A
Amendment 7
CDT · 20678X700
|
22.1% |
10/27/2026
Event 10/22/2026
|
|||
| Corvus Capital Ltd. | 16.8% | ||||
| Manoira Corporation | 14.5% | ||||
| Andrew Regan | 22.1% | ||||
|
CDT Equity Inc.
13D/A
Amendment 6
CDT · 20678X601
|
43.7% |
9/2/2026
Event 7/30/2026
|
|||
| Corvus Capital Ltd. | 43.7% | ||||
| Andrew Regan | 43.7% | ||||
|
CDT Equity Inc.
13D/A
Amendment 5
CDT · 20678X502
|
5.4% |
5/14/2026
Event 3/24/2026
|
|||
| Corvus Capital Ltd. | 5.3% | ||||
| Andrew Regan | 5.4% | ||||
|
CDT Equity Inc.
13D/A
Amendment 4
CDT · 20678X403
|
19.1% |
12/22/2025
Event 12/8/2025
|
|||
| Corvus Capital Ltd. | 12.2% | ||||
| Andrew Regan | 19.1% | ||||
|
CDT Equity Inc.
13D/A
Amendment 3
CDT · 20678X304
|
13.3% |
9/22/2025
Event 9/19/2025
|
|||
| Corvus Capital Ltd. | 1.8% | ||||
| Andrew Regan | 13.3% | ||||
| Algo Holdings, Inc. | 0% | ||||
| Manoira Corporation | 1.6% | ||||
|
Conduit Pharmaceuticals Inc.
13D/A
Amendment 2
CDT · 20678X304
|
6.0% |
7/31/2025
Event 6/3/2025
|
|||
| Corvus Capital Ltd. | 6.0% | ||||
| Andrew Regan | 6.0% | ||||
| Algo Holdings, Inc. | 0% | ||||
| Manoira Corporation | 5.3% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.